Literature DB >> 15480338

Subcutaneous immunoglobulins: alternative for the hypogammaglobulinemic patient?

Javier Chinen, William T Shearer.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15480338     DOI： 10.1016/j.jaci.2004.07.045

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN： 0091-6749            Impact factor:   10.793


× No keyword cloud information.
  4 in total

1.  Subcutaneous immunoglobulin therapy for the treatment of multifocal motor neuropathy: a case report.

Authors:  Patrizia Dacci; Nilo Riva; Marina Scarlato; Irmgard Andresen; Dirksteffen Schmidt; Giancarlo Comi; Raffaella Fazio
Journal:  Neurol Sci       Date:  2010-06-24       Impact factor: 3.307

2.  Subcutaneous immunoglobulin in treating inflammatory neuromuscular disorders.

Authors:  Min-Suk Yoon; Ralf Gold; Antonios Kerasnoudis
Journal:  Ther Adv Neurol Disord       Date:  2015-07       Impact factor: 6.570

Review 3.  Subcutaneous immunoglobulin for primary and secondary immunodeficiencies: an evidence-based review.

Authors:  Jenny Lingman-Framme; Anders Fasth
Journal:  Drugs       Date:  2013-08       Impact factor: 9.546

4.  A Multi‑Center, Open‑Label, Single‑Arm Trial to Evaluate the Efficacy, Pharmacokinetics, and Safety and Tolerability of IGSC 20% in Subjects with Primary Immunodeficiency.

Authors:  Manuel Santamaria; Olaf Neth; Jo A Douglass; Gergely Krivan; Robin Kobbe; Ewa Bernatowska; Sofia Grigoriadou; Claire Bethune; Anita Chandra; Gerd Horneff; Michael Borte; Anja Sonnenschein; Pavlina Kralickova; Silvia Sánchez Ramón; Daman Langguth; Luis Ignacio Gonzalez-Granado; Laia Alsina; Montse Querolt; Rhonda Griffin; Carrie Hames; Elsa Mondou; Jeffrey Price; Ana Sanz; Jiang Lin
Journal:  J Clin Immunol       Date:  2022-01-01       Impact factor: 8.542
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.